NO872461L - Fremgangsmaate ved fremstilling av nye antihypertensive midler. - Google Patents
Fremgangsmaate ved fremstilling av nye antihypertensive midler.Info
- Publication number
- NO872461L NO872461L NO872461A NO872461A NO872461L NO 872461 L NO872461 L NO 872461L NO 872461 A NO872461 A NO 872461A NO 872461 A NO872461 A NO 872461A NO 872461 L NO872461 L NO 872461L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- preparation
- substituted
- independently hydrogen
- aryl
- Prior art date
Links
- 229940030600 antihypertensive agent Drugs 0.000 title 1
- 239000002220 antihypertensive agent Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- OHIVDUHJQGWYAT-UHFFFAOYSA-N C1=CN2C(C(=O)O)=CSCC2=C2C=CC=CC2=C1 Chemical class C1=CN2C(C(=O)O)=CSCC2=C2C=CC=CC2=C1 OHIVDUHJQGWYAT-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000006193 alkinyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005553 heteroaryloxy group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87375486A | 1986-06-13 | 1986-06-13 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO872461D0 NO872461D0 (no) | 1987-06-12 |
| NO872461L true NO872461L (no) | 1987-12-14 |
| NO168584B NO168584B (no) | 1991-12-02 |
| NO168584C NO168584C (no) | 1992-03-11 |
Family
ID=25362243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO872461A NO168584C (no) | 1986-06-13 | 1987-06-12 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,2,3,4,6,7,8,12b-octahydro-6-oxopyrido(2,1-a)-(2)benzazepin-4-carboxylsyrederivater |
Country Status (9)
| Country | Link |
|---|---|
| CN (1) | CN1020612C (no) |
| AT (1) | ATE81511T1 (no) |
| DE (1) | DE3782190T2 (no) |
| FI (1) | FI84481C (no) |
| HU (2) | HU201326B (no) |
| IL (1) | IL82850A (no) |
| NO (1) | NO168584C (no) |
| NZ (1) | NZ220649A (no) |
| PT (1) | PT85070B (no) |
-
1987
- 1987-06-10 NZ NZ220649A patent/NZ220649A/xx unknown
- 1987-06-11 IL IL82850A patent/IL82850A/xx not_active IP Right Cessation
- 1987-06-11 FI FI872613A patent/FI84481C/fi not_active IP Right Cessation
- 1987-06-11 PT PT85070A patent/PT85070B/pt unknown
- 1987-06-11 DE DE8787108410T patent/DE3782190T2/de not_active Expired - Lifetime
- 1987-06-11 AT AT87108410T patent/ATE81511T1/de not_active IP Right Cessation
- 1987-06-12 HU HU8990A patent/HU201326B/hu not_active IP Right Cessation
- 1987-06-12 NO NO872461A patent/NO168584C/no not_active IP Right Cessation
- 1987-06-12 CN CN87104166A patent/CN1020612C/zh not_active Expired - Fee Related
- 1987-06-12 HU HU872684A patent/HU197328B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ220649A (en) | 1990-09-26 |
| DE3782190T2 (de) | 1993-02-25 |
| IL82850A (en) | 1991-03-10 |
| FI872613A7 (fi) | 1987-12-14 |
| NO168584B (no) | 1991-12-02 |
| DE3782190D1 (de) | 1992-11-19 |
| CN1020612C (zh) | 1993-05-12 |
| IL82850A0 (en) | 1987-12-20 |
| HU197328B (en) | 1989-03-28 |
| FI84481C (fi) | 1991-12-10 |
| FI872613A0 (fi) | 1987-06-11 |
| CN87104166A (zh) | 1988-01-20 |
| PT85070A (en) | 1987-07-01 |
| NO168584C (no) | 1992-03-11 |
| FI84481B (fi) | 1991-08-30 |
| PT85070B (pt) | 1990-03-08 |
| NO872461D0 (no) | 1987-06-12 |
| ATE81511T1 (de) | 1992-10-15 |
| HUT44518A (en) | 1988-03-28 |
| HU201326B (en) | 1990-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO164983C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive carboxyalkyldipeptider. | |
| DK20987A (da) | Peptidylaminodioler og fremgangsmaade til deres fremstilling | |
| BG102792A (bg) | Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама | |
| ATE12042T1 (de) | Aminosaeurederivate und ihre therapeutische verwendung. | |
| ES8801245A1 (es) | Un procedimiento para preparar derivados de piperidina | |
| DK0383686T3 (da) | Carboxyalkylethere af 2-amino-7-hydroxytetralin samt fremgangsmåde til fremstilling deraf | |
| BR9707250A (pt) | Dihidrobenzofurano e compostos correlatos úteis como agentes antiinflamatórios | |
| ATE83234T1 (de) | Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung. | |
| DK165247C (da) | 2,3,4,5-substituerede 1,6-naphthyridinderivater, deres fremstilling samt anvendelse af disse til fremstilling af laegemidler til bekaempelse af cardiale, cerebrale og perifere karlidelser, myocardial iskaemi, cerebral infarkt, lungethrombose, stenoser, arterioscleroser og hjerte-kredsloebslidelser og laegemiddel indeholdende disse derivater | |
| ES508706A0 (es) | "procedimiento de preparar acidos aroilaminicos y similares". | |
| NO872461L (no) | Fremgangsmaate ved fremstilling av nye antihypertensive midler. | |
| ATE16010T1 (de) | Neue hydrocortison-derivate, ihre herstellung und verwendung. | |
| IE781382L (en) | Indole derivatives | |
| NO852471L (no) | Fremgangsmaate for fremstilling av heterocyklylfenylformamidiner. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN DECEMBER 2000 |